Replies to post #10718 on Momenta Pharmaceuticals, Inc. (MNTA)

[rajaram46]

What recourse does Teva now on the process patent?

Finally some good news on the legal front.....

[vinmantoo]

{{It means Teva's 2015 process patent is unenforceable and hence MNTA/NVS (and MYL) can launch generic Copaxone in May 2014, pending FDA approval.}}

Wow, MNTA finally had a legal decision go its way. I am in shock. Well, MNTA's lawyers weren't involved so maybe it isn't such a shock after all. :)

[DewDiligence]

MNTA’s own PR on today’s Copaxone ruling:

http://finance.yahoo.com/news/momenta-pharmaceuticals-announces-potential-2014-171852956.html

"We are extremely pleased with today's ruling," said Craig Wheeler, President and Chief Executive Officer of Momenta. "Given the decision, we and Sandoz will continue to work with FDA to advance review of the ANDA for generic Copaxone in order for this product to be approved and available to patients as soon as possible."